Yongcong Zhang - Publications

Preoperative Nutritional Risk Defines Treatment Tolerance and Guides Adjuvant Immunotherapy in Resectable Esophageal Squamous Cell Carcinoma.

Journal: Annals of surgical oncology

Published: March 24, 2026

Lymphovascular and perineural invasion guides adjuvant therapy after neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma.

Journal: The oncologist

Published: December 23, 2025

Prognostic impact of advanced lung cancer inflammation index and tumor load index in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy.

Journal: Frontiers in immunology

Published: October 13, 2025

Impact of clinical decisions on patient outcomes after neoadjuvant therapy in locally advanced resectable esophageal squamous cell carcinoma.

Journal: Surgical endoscopy

Published: May 29, 2025

The role of pathological response in predicting the benefit of adjuvant therapy after neoadjuvant chemoimmunotherapy in patients with esophageal cancer.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 27, 2025

Ginsenoside Rg3 exerts anticancer effects in lung cancer through metabolite Histon H3.

Journal: American journal of translational research

Published: January 24, 2025

Tumor Regression Grade as a Predictor of Adjuvant Therapy Benefits in Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Therapy.

Journal: Cancer medicine

Published: December 27, 2024

Risk factor analysis and predictive model development for air leakage after thoracoscopic pulmonary wedge resection.

Journal: Journal of thoracic disease

Published: July 10, 2024

Postoperative follow-up strategy based on event dynamics for esophageal squamous cell carcinoma.

Journal: Annals of translational medicine

Published: May 14, 2021